Health Care Select Sector SPDR Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (38)

Latest Posts

About This Stock More About This Stock
Biotechs Running Again: Life Science Stocks
Article By: Rod Raynovich
Tuesday, April 25, 2017 11:59 PM EDT
Biotechs are running again taking the cue from Nasdaq which is up 3.44% in April after a brief mid-month sell-off. Biotech stocks rallied from global macro concerns which has dampened investor enthusiasm over the past two months.
In this article: BMY, FBIOX, IBB, QQQ, AMGN, GILD, XBI, XLV, ABBV, BLUE, FMI Also: RHHBY, BIIB
Read
Technically Speaking: Return Of The Bull…For Now
Article By: Lance Roberts
Tuesday, April 25, 2017 7:20 AM EDT
If the market can reverse course next week, and move back above the 50-dma AND break the declining price trend from the March highs, then an attempt at all time highs is quite likely.
In this article: EEM, XLB, XLE, XLF, XLI, XLK, XLP, XLU, XLV, XLY, SPX
Read
Is Pain Ahead For Healthcare ETFs After Weak JNJ Q1?
Article By: Sweta Killa
Monday, April 24, 2017 1:38 PM EDT
The hot healthcare sector has made a nice comeback this year on cheap valuation, robust earnings results, encouraging industry trends, and a slew of positive actions taken by the President despite the collapse of the healthcare bill.
In this article: XLV, VHT, IYH, FHLC, SPY Also: JNJ, PFE, MRK, AMGN, ABBV, GILD, BMY
Read
Real Estate ETFs Climb In Sector Rankings
Article By: Ron Rowland
Wednesday, April 12, 2017 10:23 PM EDT
Utilities tops the sector rankings, but it was the Real Estate ETFs making the largest upside move. Financials, the prime post-election beneficiary has run out of gas.
In this article: IYR, XLF, XLK, XLU, XLV
Read
Biotech In A Doldrums: Rallies Interrupted By Geopolitics, Trump Agenda And Flight To Safety
Article By: Rod Raynovich
Tuesday, April 11, 2017 7:38 PM EDT
Recent geopolitical news has created a backdrop that has discouraged investors in biotech who were already risk averse from drug pricing issues. There has been little momentum over since mid-march with choppy sluggish trading.
In this article: RHHBY, IBB, ILMN, GILD, HOLX, VRTX, XBI, XLV, BLUE
Read

PARTNER HEADLINES

Latest Tweets for $XLV

No tweets yet!